Mr. Qiao, a 52-year-old male patient with gastric cancer from Heze City, Shandong Province, was treated at Jiaozuo Zhonghai Traditional Chinese Medicine Oncology Hospital. Half a year ago, he was diagnosed with gastric adenocarcinoma with liver metastasis at a local hospital due to symptoms such as abdominal pain and distension. This heavy diagnosis hung over his life like a dark cloud.
Subsequently, Mr. Qiao received standard treatment at the local hospital, including chemotherapy combined with targeted therapy. The specific regimen was a combination of oxaliplatin, capecitabine, and sintilimab, for a total of 6 cycles. However, his condition was not controlled as expected; instead, it progressed, with the tumors increasing in size and number. Faced with this difficult situation, the local doctors adjusted the treatment plan and switched to sintilimab plus tegafur-gimeracil-oteracil (S-1).
On the recommendation of other patients, Mr. Qiao came to Jiaozuo Zhonghai Traditional Chinese Medicine Oncology Hospital with a glimmer of hope. At the time of consultation, he presented with symptoms such as stomach discomfort, poor digestion, bitter taste in the mouth, hiccups after feeling cold, and palpitations. His appetite was average, and his bowel and bladder functions were relatively normal.
After fully understanding Mr. Qiao’s condition, Director Zhang of our hospital formulated a treatment plan: an empirical formula for gastric tumors (adjusted according to symptoms), supplemented with Hua’ai Xiaoliu Powder (Anti-Cancer Tumor-Eliminating Powder), while continuing the targeted therapy and immunotherapy.
After taking 10 doses of the medication, Mr. Qiao experienced encouraging improvements—all of the aforementioned symptoms were alleviated compared with before.
